CTLA4 and melanoma: As a consequence of the molecular biology experiments, we have found that inhibiting CNTFR activity exerted a reverse regulatory role in the proliferation and migration of melanoma cells, but facilitated the expression of immune checkpoints (PD-1, PD-L1, and CTLA4).